Poor prognosis for malignant melanoma in Northern Ireland: a multivariate analysis. by Gordon, L. G. et al.
Br. J. Cancer (1991), 63, 283 286
© Macmillan 1991
Poor prognosis for malignant melanoma in Northern Ireland: a
multivariate analysis
L.G. Gordon', W.S. Lowry', P.J. Pedlow' & C.C. Patterson2
'Department ofOncology, Queen's University ofBelfast, Whitla Medical Building, 97 Lisburn Road, Belfast B79 7BL;
2Department ofEpidemiology and Public Health, Queen's University ofBelfast, Mulhouse Building, Grosvenor Road, Belfast BT12 6BJ, UK.
Summary All cases of cutaneous malignant melanoma, CMM, diagnosed in Northern Ireland between
1974-1978 were reviewed, classified and followed up until the end of 1984. The overall 5 year survival is 54%,
among the worst reported in recent literature. Multivariate analysis of these cases confirms some previous findings from other studies, but also reveals features not apparent in univariate analysis. Prognosis worsens
with increasing thickness and the presence of ulceration. Likewise histopathological type has an independent
effect on survival, ALM having the worst prognosis. Tumour profile emerges as a significant feature affecting
prognosis, flat lesions having the poorest outlook, given their thickness. Survival is worse with increasing age.
Anatomical site is less important than suggested by previous univariate analysis. Sex has little influence on
prognosis when adjusted for the other variables. Cell type and pigmentation are of no prognostic value.
Several features including diagnostic delay contribute to the poor overall survival for CMM in Northern
Ireland. Educational intervention is essential if this trend is to be reversed.
Malignant melanoma continues to cause concern. Its inci-
dence and mortality is increasing in most countries studied.
Depletion of the ozone layer in the northern hemisphere has
led to disturbing predictions that this trend will continue for
all forms of skin cancer well into the next century (Mackie,
1988).
Previous studies (Gordon & Lowry, 1986a) indicated that
the incidence of malignant melanoma in Northern Ireland is
similar to that found in other population-based studies,
although lower than reported in Norway or Australia. A
female to male ratio of approximately three to one was noted
in the province, the highest sex ratio so far reported in the
literature. The distribution of histopathological types was
also unusual with a lower incidence of Superficial Spreading
Melanoma, SSM (27%), than reported elsewhere, and rela-
tively higher proportions of Nodular Melanoma, NM (42%),
Lentigo Maligna Melanoma, LMM (20%), and Acral Lentig-
inous Melanoma, ALM (11%). More worrying was the find-
ing that patients in Northern Ireland presented with more
advanced disease than in any other major incidence study.
This is usually related to the clinical stage of the disease.
Unfortunately this clinical information was often not avail-
able in this retrospective survey, and advanced disease was
therefore defined by the Breslow thickness of the lesion.
Sixty-seven per cent of lesions were thicker than 1.7mm;
alternatively 75% of lesions were thicker than 1.5 mm. Both
of these thicknesses have been described as 'natural break
points'. The current study was set up to determine to what
extent these 'advanced' cases resulted in decreased survival
and to examine other factors independently associated with
poor prognosis. The pattern of more advanced presentation
of melanoma in the province permits an analysis of prognos-
tic factors at a later stage in the pathogenesis of the disease.
Methods
The histopathological records of all suspected cases of malig-
nant melanoma in Northern Ireland for the 5 year period
between 1974-78 were reviewed microscopically. It was
important to identify each new biopsy proven case that
occurred during the study period. At the time, there were
only three pathology centres in Northern Ireland and all
biopsy specimens were submitted to these centres. Details on
the methodology were given in the previous incidence study
(Gordon & Lowry, 1986a). The initial survey revealed 304
cases. Eye lesions and metastases were then excluded. Also
excluded were 37 non-invasive lesions, 15 cases of lymph
node melanoma with no identifiable primary site and eight
cases of nasal, vaginal and anal mucosal melanoma, where
there was no involvement ofstratifying squamous epithelium.
Four doubtful cases of melanoma were excluded following
further histological examination. The remaining 240 cases
fulfilled the diagnostic criteria of invasive CMM and formed
the basis of the present follow-up diagnostic study. As out-
lined in the previous paper, the cases were considered to
represent essentially all patients with melanoma in Northern
Ireland.
Information on survival and cause of death was obtained
from a number of sources, including hospital notes, general
practitioner records, and death certificate data from the
Registrar General of Northern Ireland. When this failed to
provide adequate information, personal contact was made
with individual patients or their surviving relatives through
home visits, or through direct enquiries to the family doctor.
In this way complete follow-up was obtained for 226 of the
240 patients until the end of 1984, 14 patients being lost to
follow-up at this time. Univariate analysis was performed on
these cases. The features considered for analysis were pub-
lished in the previous incidence study and included: thick-
ness, age, sex, tumour type, site, profile, ulceration, cell type
and pigmentation. Complete data on all these covariates was
available for 214 patients and multivariate analysis was per-
formed on these cases for the period ending December 31st
1984.
Additional follow-up until December 1988 has recently
been obtained using Central Services Agency records and
data from the Office of the Registrar General. A further three
patients were lost to follow-up at 10 years. The remaining
223 patients were analysed only to determine the 10 year
survival figures.
Survival curves were calculated using the method of Kap-
lan and Meier (Kaplan & Meier, 1958). Initial univariate
analysis using the log rank test (Peto, 1977) examined the
relationship of each feature individually with survival. Some
variables affect prognosis only because of their relationships
with other variables. It is important therefore to identify
those variables that are independently associated with sur-
vival. For this purpose the incidence study provided valuable
information on the relationship between variables. The pro-
portional hazards regression model (Cox, 1972) was used for
the final multivariate analysis.
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The results of both the log rank test and the proportional
hazards model analyses may be summarised in terms of
relative hazards. For categorical variables, these indicate the
risk of death in one subgroup relative to another. For the
variables age and Breslow thickness, which were included in
the proportional hazards model as continuous variables, the
relative hazards represent the increase in risk associated with
a decade's increase in age and a doubling of thickness respec-
tively.
Results
Overall survival
During the first 5 years of follow-up 125 patients died of
whom 93 (74%) had melanoma listed as the cause of death.
Life table estimates, with standard errors, for 1, 5 and 10
year survival, of the group as a whole, are 86.4% (s.e. 2.3%),
53.5% (s.e. 3.3%) and 42.2% (s.e. 3.7%) respectively (Figure
1). The greatest risk of death occurs in the first 2 years
following excision. Notification of deaths to December 1988
became available at the end of the study and confirmed a 10
year survival of 42.7%.
Of the 32 deaths (26%) whose primary cause of death was
not given as melanoma, 27 deaths were due to cardiovascular
disease, three to unrelated carcinoma, one to pulmonary
embolus and one unknown. These 32 patients belonged pre-
dominantly to the older age bands, 14 being over 80 years
and a further 11 over 70 years. It is possible that some of
these deaths were also due to melanoma although this may
not have been recognised at the time.
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Figure I Actuarial survival plot
Age Prognosis worsens with increasing age at diagnosis.
Sex Females have a better prognosis than males.
Site Lesions on the foot have the worst prognosis followed
by the trunk, head and neck, hand and arm, and leg respec-
tively.
Pigmentation Heavily pigmented lesions have the worst
prognosis followed by amelanotic lesions. Those with mild-
moderate pigmentation have the best prognosis.
Cell type This is not significantly associated with prognosis.
Multivariate analysis
The results of multivariate analysis are given as estimated
relative hazards in Table II.
Table I Results of univariate analysis by the log rank test
Log rank
Variable Relative hazard chi square
Sex
Female vs Male 0.66 <0.05
Age
35-49 vs<35 1.38
50-64 vs<35 2.03 <0.001
65-79 vs<35 3.13
,80vs<35 6.07)
Site
Trunk vs Head and neck 1.27
Hand and arm vs Head and neck 0.77 <0.01
Leg vs Head and neck 0.52
Foot vs Head and neck 1.71
Type
Nodular vs LMM 1.02
SSM vs LMM 0.94 ) <0.001
ALM vs LMM 3.04)
Clark Level
3vs2 4.17)
4 vs 2 4.32) <0.001
5vs2 10.64)
Breslow measurement
0.75- 1.49 vs<0.75 3.96
1.50-2.99 vs<0.75 4.74 <O 001
3.00-3.99 vs<0.75 6.24 )
>4.00vs<0.75 11.04)
Profile
Convex or plateau vs flat 0.68 <0.05 Polypoid vs flat 1.15 )
Ulceration
Present vs Absent 2.97 <0.001
Pigmentation
Mild to moderate vs none 0.58 <0001
Heavy vs none 1.86 )
Univariate analysis
The features considered initially in univariate analysis are
given in Table I and are interpreted below:
Thickness Prognosis worsens with increasing Clark level
and increasing Breslow measurement.
Ulceration The presence of ulceration is associated with a
marked worsening of prognosis.
Histopathological type ALM has a notably poorer prognosis
than other types.
Profile Convex/plateau profile has the best prognosis fol-
lowed by flat profile. Polypoidal/pedunculated profile has the
worst prognosis.
Table II Estimated relative hazards from a proportional hazards
model
95% Likelihood
Relative Confidence ratio
Variable hazard limits chi square
Age
(per decade) 1.24 (1.08, 1.42) P<0.01
Type
Nodular vs LMM 1.01 (0.56, 1.82)
SSM vs LMM 1.93 (1.00, 3.72) P<0.01
ALM vs LMM 2.50 (1.28, 4.86)
Breslow thickness
(log2 scale) 1.52 (1.22, 1.88) P<0.001
Profile
Convex plateau vs flat 0.50 (0.28, 0.92) P<0.0l Polypoidal vs flat 0.33 (0.17, 0.61)
Ulceration
Present vs absent 2.63 (1.53, 4.51) P<0.001POOR PROGNOSIS FOR MALIGNANT MELANOMA 285
Thickness The most important factor determining survival
is thickness of the primary lesion measured in millimetres, the
Breslow measurement. As the distribution of thickness was
positively skewed, this variable was log transformed before
including it in the multivariate analysis. Logarithms to base
two were used, so the co-efficient for thickness in Table II
represents the relative hazard associated with double the
thickness of the tumour. As expected prognosis worsens with
both increasing Clark level and Breslow measurement (P<
0.001). However Clark level is no longer significant when
adjusted for Breslow measurement, indicating that the prog-
nostic value of the Clark level is contained in the Breslow
measurement.
Ulceration Ulceration is also shown to be an independent
indicator of prognosis. Thicker lesions tend to be ulcerated
more often than thinner lesions, but the presence of ulcera-
tion worsens prognosis independently of thickness. This con-
tains prognostic information not available in the other
covariates. In this series 58% of all lesions are ulcerated.
Histopathological type Tumour type is independently related
to prognosis. Multivariate analysis reveals a degree of over-
lap in the prognostic information supplied by type and site.
However type remains prognostically significant after adjust-
ment for age, thickness and site (P<0.01). Type is thus
independent of site, but not vice versa. ALM has the worst
prognosis. SSM has an intermediate prognosis, NM and
LMM are similar and have the best prognosis.
Profile Tumour profile provides an independent indication
of survival in this population. When adjusted for Breslow
measurement, profile becomes highly significant (P<0.001)
and remains so after further adjustment for age and site. In
contrast to univariate analysis, flat profile tumours have the
worst prognosis, given their thickness, followed by convex/
plateau and then polypoidal/pedunculated lesions. Flat mela-
nomas therefore have a higher risk than their thickness
would suggest. In this study 47% of flat profile tumours are
thin (<0.76 mm), and 37% are thick (> 1.7 mm) with 30%
greater than 4 mm thickness.
Age Age is a significant independent prognostic factor in
survival. Adjustment for thickness reduces the significance of
age because older patients tend to have thicker lesions. The
relative hazard for age shows a 24% increase in risk per
decade of age at diagnosis.
Sex Although females in Northern Ireland fare marginally
better than males in univariate analyses, multivariate analysis
shows that sex is not independently significant. The superior-
ity in female survival can be explained by the high propor-
tion of female tumours occurring on the lower limb (33%
female, 12% males) and the greater proportion of males with
lesions thicker than 1.7 mm (82% males, 62% females).
Site Site remains significant when adjusted individually for
all other factors except tumour type. After simultaneous
adjustment for age, type and Breslow measurement however,
site is not significant. This adjustment reduces the risk of
tumours of the foot to that of the head and neck. Thus the
poor prognosis for lesions of the foot can be explained by the
fact that they not only tend to be thick lesions occurring in
older patients, but more importantly because the majority are
ALM lesions.
Other features Cell type and pigmentation are of no inde-
pendent prognostic value.
Conclusion
In conclusion five features make a statistically significant
independent contribution to survival in this study. These are:
(i) Thickness in millimetres.
(ii) Ulceration.
(iii) Histopathological type.
(iv) Tumour profile.
(v) Age.
Table II shows how these variables are used to construct a
final proportional hazards model as a guide to prognosis.
Discussion
The previous study indicated that patients in Northern Ire-
land presented with more advanced melanomas, as defined
earlier, than elsewhere (Gordon & Lowry, 1986a). The pre-
dicted poor survival of these patients is confirmed in the
present study. The 5 year survival of 54% is among the worst
reported in recent literature. As many of these patients die in
the first 2 years following diagnosis, advanced malignant
melanoma is a rapidly fatal condition. After 5 years the
survival curve begins to flatten but the 10 year survival of
43% underlines the gloomy prognosis. The relatively high
proportion of 26% non-melanoma deaths appears to be
largely due to cardiovascular disease in elderly patients.
Thickness in mm emerges as the single most important
factor determining prognosis in this population. This agrees
with other studies (Breslow, 1970; Mackie et al., 1985).
Thickness linked to diagnostic delay has been proposed as
the reason for poor prognosis in Britain and in Ireland
(Doherty & Mackie, 1986).
Ulceration has also been associated with poor prognosis
(Balch et al., 1980). In the present study, ulceration denotes a
particularly aggressive lesion.
Histological sub-type is important. ALM has the worst
prognosis in both univariate and multivariate analysis, sug-
gesting that this is due to the aggressive nature of this
tumour type, rather than the difficulty in diagnosing less
visually accessible lesions. Although numbers are small, the
adequacy of the estimate is shown by the confidence limits in
Table II. These are quite wide reflecting the small proportion
of patients with ALM. In keeping with other studies, LMM
has the best prognosis (Larsen & Grude, 1986). This advan-
tage is unfortunately offset by the thickness of many LMM's
in the province.
Some studies have suggested that profile is not significant
once thickness is taken into account. However our study
indicates that profile is important. Although univariate anal-
ysis suggests that polypoid tumours fare worse, in multi-
variate analysis flat tumours have the worst prognosis when
their thickness is taken into account. Regression may partly
account for this finding. It has been suggested that thin
tumours less than 0.76mm showing evidence of regression
have a poor prognosis (Gromet et al., 1978; Shaw et al.,
1980). However flat lesions are not necessarily'thin. In fact
less than half the flat tumours in this study are thin. Unfor-
tunately however the importance of regression as a covariate
was not widely recognised when this study was initiated and
it was not recorded.
Age is a weak but significant independent prognostic fac-
tor. This could be due to less aggressive treatment in the
elderly, perhaps associated with less resistance to disease.
Studies indicate that ultra violet radiation suppresses immune
defence mechanisms and this may be more pronounced in
older patients.
Females survive longer not because they are females, but
because they have relatively thin lesions on the lower leg. It
may be that it is not their sex that makes the difference but
their behaviour. Women dress differently from men, are more
aware of skin blemishes, and presumably attend their doctor
more promptly. But if females have earlier lesions, they
unfortunately have more lesions. The increased incidence of
malignant melanoma in women in Ireland may also be relat-
ed to behavioural differences between the sexes and attitudes
to sun tanning. The three to one female to male melanoma
ratio has recently been noted in separate studies in Dublin
and Cork in the Republic of Ireland (O'Loughlin et al.,
1989).
The finding that prognosis is determined by type and286 L.G. GORDON et al.
profile may be linked to the progression of the disease. The
relative role of different aetiological factors will depend on
the weighting of these factors in different populations.
The examination of many variables can make interpreta-
tion difficult as there is always the possibility of type I error.
However this is 'Unlikely in the present study as all the
variables in the final model are significant to the 1% level or
better. The model is nonetheless idiosyncratic. It is generated
from an unusual group of patients, 67% of whom have
lesions thicker than 1.7 mm at presentation. Moreover, the
unusually high female to male sex ratio distribution has not
been noted outside Ireland, and the distribution of histo-
pathological types does not match that found elsewhere. The
model is therefore primarily applicable to Northern Ireland.
In addition, not all the important variables were available for
analysis in this retrospective study. As already noted, clinical
stage was unfortunately often not recorded at the time of the
study. In retrospect it is likely that a population with such
late presentation would have had a relatively high proportion
of Stage II or Stage III disease.
It is regretted that this important variable was not includ-
ed. Not surprisingly it has been shown that the risk of dying
from melanoma in Stage II-III disease is much greater than
in Stage I disease. Information on stage is being collected in
a current study covering the subsequent decade, bearing in
mind that the level of clinical, surgical and pathological
staging in any form of cancer is, to some extent, a measure
of the intensity of the clinical investigations performed.
Inevitably some patients with so-called Stage I disease will
have small undetected metastases. An unstaged series is of
some value, but it does limit the comparability of this investi-
gation.
Again, the value of mitotic activity was not clearly defined
when the study was initiated. The idiosyncratic features of
the population and the impact of the additional variables are
recognised. For instance the influence of sex on prognosis
might be expected to be different for Stage I and Stage II
disease. However it is difficult to speculate on the exact
influence of these additional variables in any precise way.
Information on mitotic activity is also now being collected in
a current study covering the subsequent decade. Finally it
was not considered necessary to test the model in a 'hold
back' sample. The use of a 'hold back' sample or 'test set' is
not standard practice in survival analysis, although it is so in
discriminant function analysis in which predictions or alloca-
tions are made. We chose to model the results primarily to
improve understanding of the relationship between the co-
variates and survival rather than to make predictions. The
inclusion of a 'hold back' sample would have led to a reduc-
tion in the precision of relative hazard estimates.
In conclusion the reduced survival for melanoma in North-
ern Ireland fits the poor overall health pattern found for
other diseases in the province. Socio-economic factors have
been blamed for much of this morbidity and mortality, but
cannot entirely account for the dismal prognosis with melan-
oma. National Health Service facilities are available for all
patients to receive prompt treatment for skin cancer.
Northern Ireland has a maritime climate and lies between
54°N-56°N. In common with Scandinavia and Scotland at
similar latitudes there has been a 6-7% depletion in the
ozone layer since 1970, and a consequent increase in the
ultraviolet flux (NASA, 1988). This factor along with the
Celtic skin type, the greater availability of sunbeds and
package holidays, the sun-tan 'status symbol', the general
lack of awareness of the dangers of solar skin damage, and
diagnostic delay have all contributed to the problem of
melanoma in Northern Ireland. Equally worrying is the lack
of professional awareness leading to diagnostic delay by doc-
tors in some cases (Gordon & Lowry, 1986b). The cumula-
tive results of all these factors are clearly demonstrated in
this study. The extent to which these findings apply will vary
from country to country. In Northern Ireland educational
intervention is essential if the present trend is to be reversed.
References
BALCH, C.M., WILKINSON, M.D., MURAD, R.M,. SOONG, S., ING-
ALLS, A.L. & MADDOX, W.A. (1980). The prognostic significance
of ulceration of cutaneous melanoma. Cancer, 45, 3012.
BRESLOW, A. (1970). Thickness, cross sectional area and depth of
invasion in prognosis of cutaneous melanoma. Ann. Surg., 172,
902.
COX, D.R. (1972). Regression models and life tables. J. R. Statist.
Soc., B34, 187.
DOHERTY, V.R. & MAcKIE, R.M. (1986). Reasons for poor prognosis
in British patients with cutaneous malignant melanoma. Br. Med.
J., 292, 987.
GORDON, L. & LOWRY, W.S. (1986a). The incidence and patho-
genesis of invasive cutaneous malignant melanoma in NI. Br. J.
Cancer, 53, 75.
GORDON, L.G. & LOWRY, W.S. (1986b). Missed malignant melano-
mas. Br. Med. J., 292, 1524.
GROMET, M.A., EPSTEIN, W.L. & BLOIS, M.S. (1978). The regressing
thin malignant melanoma. A distinctive lesion with metastatic
potential. Cancer, 42, 2282.
KAPLAN, E.L. & MEIER, P. (1958). Non parametric estimation from
incomplete observations. J. Am. Stat. Assoc., 53, 457.
LARSEN, T.E. & GRUDE, T.H. (1986). A retrospective histological
study of 669 cases of primary CMM in clinical stage I. Acta.
Path. Microbiol. Scand. Sect. A., 86, 437.
MACKIE, R.M., SOUTER, D.S., WATSON, A.C.H. & 9 others (1985).
Malignant melanoma in Scotland 1979-83. Lancet, ii, 859.
MACKIE, R. (1988). Health and the ozone layer. Br. Med. J., 297,
369.
NASA (1988). Ozone Trends, Panel Report.
O'LOUGHLIN, S., DERVAN, P. & MORAN, M.A. (1989). Changing
patterns of melanoma. European Cancer Year Conference, Irish
Cancer Society: Dublin.
PETO, R. (1977). Design and analysis of randomized clinical trials
requiring prolonged observation of each patient. II Analysis and
examples. Br. J. Cancer, 35, 1.
SHAW, H.M., MCGOVERN, V.J., MILTON, G.W., FARAGO, G.A. &
MCCARTHY, W.H. (1980). Histologic features of tumors and the
female superiority in survival from malignant melanoma. Cancer,
45, 1604.